Levetiracetam is an antiepileptic drug (AED) with a favourable tolerability profile with little or no effect on liver function. We describe an epileptic patient who developed a significant increase in gamma glutamyltransferase (gammaGT) while on levetiracetam monotherapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1684/epd.2010.0291 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!